New Research Explores Single-Dose Treatment for Type 1 Diabetes
Scientists investigate the potential of a single intravenous dose of engineered bacteria to delay or prevent Type 1 diabetes in mice.
Key takeaways
- Researchers used an indole-producing attenuated Brucella strain to treat prediabetic mice.
- The treatment was given as a single intravenous dose, and its effects were monitored over several weeks.
- The study found that the treatment delayed or prevented Type 1 diabetes in some mice.
What is Type 1 Diabetes?
Type 1 diabetes is a chronic autoimmune disease where the body's immune system attacks and destroys the insulin-producing beta cells in the pancreas. This leads to high blood sugar levels, which can cause a range of complications if left unmanaged.
New Treatment Approach
In this study, researchers used an engineered strain of Brucella bacteria that produces indole, a compound with immunomodulatory properties. The bacteria were given as a single intravenous dose to prediabetic mice, which are genetically prone to developing Type 1 diabetes.
How Did the Treatment Work?
The researchers monitored the mice's blood glucose levels over several weeks and found that the treatment delayed or prevented the onset of Type 1 diabetes in some animals. The study also looked at changes in the pancreas, including islet immune remodeling and insulin production.
What Do These Findings Mean?
While this study was conducted in mice and more research is needed to confirm its findings, it provides promising insights into new treatment approaches for Type 1 diabetes. A single-dose therapy could potentially offer a simpler and more effective way to manage the disease.
Evidence label
Source: Journal of visualized experiments : JoVE. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.